© Coherent market Insights. All Rights Reserved CANCER BIOMARKERS MARKET Global Market Analysis, Insights, Trends, and Opportunity Inference, © Coherent market Insights. All Rights Reserved

REPORT DESCRIPTION Cancer is the second-leading cause of death worldwide (World Health Organization). There were around 14 million new cases of cancer reported across the globe in 2012 and the incidence rate is expected to increase by around 70% by 2030 (WHO). The most common cancer types are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer. Cancer therapies are expensive and the cost rises with increase in complexity or stage of the caner condition. Therefore, understanding cancer biomarkers is the key to developing the right treatment plan for a cancer patient. Biomarkers indicates one’s health condition and the underlying disease condition. Various types of biomolecules such as DNA, proteins, and hormones are widely used to detect the malady. These biomarkers can be found in blood, urine, stool, tumor tissue, or other body fluids. Different cancer biomarkers react differently to various cancer treatments. There are increasing efforts to diagnose cancer at an early stage, which would drive the global cancer biomarkers market growth. However, poor reimbursement policies is negatively impacting market growth. Cancer Biomarkers Market Taxonomy The global cancer biomarkers market can be segmented on the basis of biomarker type, cancer type, application, and biomarker profiling technologies. On the basis of biomarker type, the market is segmented into protein biomarker, genetic biomarker and cellular biomarkers, and others. Cancer Biomarkers Market Overview

© Coherent market Insights. All Rights Reserved Cancer Biomarkers Market: Regional Overview North America and Europe dominate the global cancer biomarkers market on account of high cancer diagnostic and detection procedures, high investment in research and development by pharmaceutical and biotechnology companies and better healthcare infrastructure supporting the R&D activities using biomarkers. Markets in emerging economies such as the Asia Pacific and Latin America are poised to grow at a considerable higher growth rate owing to increasing funding for cancer biomarker research, growing prevalence of cancer, increasing number of clinical trials and growing demand for targeted and personalized drug therapies. The WHO estimates that in 2015 only 35% of the low- income countries reported to have pathology services available in the public sector. The rate is extremely less compared the high-income countries, which reported 90% availability of pathology services. These factors highly govern the growth of cancer biomarkers market, as accessibility would enable uptake of this technology by the users. Request Report REPORT DESCRIPTION

© Coherent market Insights. All Rights Reserved REPORT DESCRIPTION On the basis of profiling technology, the market is segmented into omics technologies, imaging technologies, immunoassays, cytogenetic based tests, and bioinformatics. Omics technologies is widely used profiling technology in the global market. Growing demand for personalized treatment therapies, use of proteomics in cancer biomarker detection, growing demand for accurate & effective diagnostic procedures are amongst the major factors driving its market growth. Enzyme-Linked Immunosorbent Assay (ELISA) is the most widely used immunoassays profiling technology in the global cancer biomarkers industry. On the basis of application, the market is classified as drug discovery and development, diagnostics, prognostics, risk assessment and others. Cancer biomarkers are finding increasing applications in drug discovery with growing research activities on targeted cancer therapies. Some of the key players in the global cancer biomarkers market include Abbott Laboratories, Merck & Co. Inc., Affymetrix Inc., Agilent Technologies, Illumina, Inc., Roche Diagnostics Ltd, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Qiagen NV, and Hologic Inc. Request For insight/toc/175https:// insight/toc/175

© Coherent market Insights. All Rights Reserved Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. ABOUT US ABOUT COHERENT MARKET INSIGHTS SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH CONSULT STUDIES MARKET INTELLIGENCE SERVICES COUNTRY SPECIFIC STUDIES

© Coherent market Insights. All Rights Reserved  Global Leading Equipment and System Manufacturers  Component Providers and System Integrators  Distributors, Retailors and Value Added Resellers  Healthcare IT Solutions Developers  Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies  Universities and Business Schools. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGYCLINICAL DIAGNOSTICHEALTHCARE IT PHARMACEUTICALMEDICAL IMAGINGMEDICAL DEVICES OUR CLIENTS

© Coherent market Insights. All Rights Reserved Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. ABOUT US RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES TECHNOLOGY SNIPPETS EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT SURVEY RESEARCH CUSTOMIZED SOLUTIONS CONSULT PROJECTS COUNTRY ANALYSIS KEY STATS Insights Published Per Year Consulting Projects Till Date Clients Worldwide Per Year Analysts and Contract Consultants

© Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: For sales queries or new topics us on: For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights